Q2 results - how will market respond?IPA appears to be transitioning from a company which provided research to other enterprises to a company developing its own therapeutics. This may take years. Can they provide contract research at the same time as competing in the same space?
Bringing a therapy to market through the FDA takes years. Warp speed may be the new normal for the big players, or is it? IPA is not a big player; does that matter? Probably, yes.
I see that Dr Bath has started to use more agressive language. She is obviously competitive, which is important.
I expect to see the share price drop this week.
cleareye.